We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

18 hedge funds and large institutions have $4.49M invested in ImmuCell in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

13% more funds holding

Funds holding: 16 → 18 (+2)

0.42% less ownership

Funds ownership: 12.44% → 12.02% (-0.42%)

9% less capital invested

Capital invested by funds: $4.94M → $4.49M (-$453K)

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$182K
2
Northern Trust
Northern Trust
Illinois
+$75K
3
FHA
Flagship Harbor Advisors
Massachusetts
+$21.5K
4
Deutsche Bank
Deutsche Bank
Germany
+$12.2K
5
Renaissance Technologies
Renaissance Technologies
New York
+$10.8K

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$237K
2
EIM
Essex Investment Management
Massachusetts
-$224K
3
Morgan Stanley
Morgan Stanley
New York
-$10.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
HA
1
Heartland Advisors
Wisconsin
$1.36M – – –
PCM
2
Perritt Capital Management
Illinois
$1.05M – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$638K +$10.8K +1,500 +2%
Vanguard Group
4
Vanguard Group
Pennsylvania
$485K +$182K +25,300 +55%
SRC
5
Shufro Rose & Co
New York
$333K – – –
EFS
6
Essex Financial Services
Connecticut
$162K – – –
MA
7
Minerva Advisors
Pennsylvania
$98K – – –
RC
8
RBF Capital
California
$90K – – –
Morgan Stanley
9
Morgan Stanley
New York
$77K -$10.8K -1,500 -12%
Northern Trust
10
Northern Trust
Illinois
$71K +$75K +10,443 New
UBS Group
11
UBS Group
Switzerland
$39K +$5.14K +716 +14%
Deutsche Bank
12
Deutsche Bank
Germany
$31K +$12.2K +1,699 +59%
FHA
13
Flagship Harbor Advisors
Massachusetts
$20K +$21.5K +3,000 New
Bank of America
14
Bank of America
North Carolina
$13K +$22 +3 +0.1%
BlackRock
15
BlackRock
New York
$10K +$4.87K +679 +92%
Wells Fargo
16
Wells Fargo
California
$7K -$237K -33,000 -97%
TRCT
17
Tower Research Capital (TRC)
New York
$1K +$1.21K +168 New
EIM
18
Essex Investment Management
Massachusetts
– -$224K -31,969 Closed

ICCC Hedge Fund Activity: Q2 2018 in Review

18 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2018, worth a combined $4.49M — down 9.2% from $4.94M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ICCC positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $182K. The largest seller was Wells Fargo, cutting an estimated $237K.

  • 18 institutional investors held ImmuCell (ICCC) as of Q2 2018, up from 16 in Q1 2018.
  • Funds reported $4.49M of ImmuCell stock for Q2 2018, down 9.2% quarter-over-quarter.
  • 3 funds opened new ImmuCell positions in Q2 2018 and 1 closed out, a net change of +2 holders.
  • The largest ImmuCell buyer in Q2 2018 was Vanguard Group, an estimated $182K added.
  • The largest ImmuCell seller in Q2 2018 was Wells Fargo, an estimated $237K sold.

Based on aggregated 13F filings for Q2 2018.